Disease: burnout

A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics

mycolabadmin

Psychedelic compounds like psilocybin and ketamine show promise in treating serious mental health conditions including PTSD and depression. The FDA carefully evaluates these drugs through multi-phase clinical trials to ensure they are safe and effective. While California has proposed making psychedelics more widely available through legislation, the FDA’s thorough approval process provides important protections by identifying potential risks and ensuring proper medical oversight.

Read More »

Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders

mycolabadmin

Researchers tested a new group therapy approach using ketamine to help firefighters, police officers, paramedics, and healthcare workers dealing with job stress and burnout. Over seven weeks, 32 participants received three ketamine sessions combined with group therapy. The results showed significant improvements in anxiety, depression, trauma symptoms, and burnout within the group. This low-cost group approach not only helped individual symptoms but also created a supportive community where workers felt understood by others in similar situations.

Read More »
Scroll to Top